2015 Q3 Form 10-Q Financial Statement

#000107997315000532 Filed on August 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2015 Q2 2014 Q4
Revenue $60.00K $24.52K $79.00K
YoY Change 66.67%
Cost Of Revenue $10.00K $8.096K $30.00K
YoY Change -19.3%
Gross Profit $40.00K $16.42K $51.00K
YoY Change 66.67%
Gross Profit Margin 66.67% 66.98% 64.56%
Selling, General & Admin $1.230M $1.483M $1.520M
YoY Change -16.51% -11.47% 7.8%
% of Gross Profit 3075.0% 9028.73% 2980.39%
Research & Development $430.0K $552.4K $900.0K
YoY Change -61.58% -41.86% -45.45%
% of Gross Profit 1075.0% 3364.03% 1764.71%
Depreciation & Amortization $36.00K $38.00K $70.00K
YoY Change -23.4% -25.49% -12.5%
% of Gross Profit 90.0% 231.41% 137.25%
Operating Expenses $1.640M $2.035M $2.390M
YoY Change -36.74% -22.47% -21.64%
Operating Profit -$1.600M -$1.994M -$2.339M
YoY Change -37.12% -23.31% -23.31%
Interest Expense $10.00K $24.20K -$20.00K
YoY Change -63.22% -6.1% -80.0%
% of Operating Profit
Other Income/Expense, Net -$38.81K $0.00
YoY Change -523.13% -100.0%
Pretax Income -$1.580M -$2.030M -$2.370M
YoY Change -37.55% -21.62% -24.28%
Income Tax
% Of Pretax Income
Net Earnings -$1.580M -$2.033M -$2.370M
YoY Change -37.62% -21.54% -24.28%
Net Earnings / Revenue -2633.33% -8293.16% -3000.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$408.3K -$524.5K -$610.8K
COMMON SHARES
Basic Shares Outstanding 30.99M shares 30.99M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q3 2015 Q2 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $18.90M $20.40M $24.50M
YoY Change -29.21% -29.9% 71.33%
Cash & Equivalents $3.200M $4.868M $3.540M
Short-Term Investments $15.70M $15.60M $21.00M
Other Short-Term Assets $500.0K $200.0K $400.0K
YoY Change 0.0% -33.33% -20.0%
Inventory
Prepaid Expenses
Receivables $58.00K $24.00K $17.00K
Other Receivables
Total Short-Term Assets $19.40M $20.59M $24.90M
YoY Change -28.81% -29.91% 68.66%
LONG-TERM ASSETS
Property, Plant & Equipment $2.000M $2.026M $2.104M
YoY Change -6.18% -6.47% -7.19%
Goodwill $387.2K $387.2K $387.2K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.714M $1.724M
YoY Change 2.38% 6.95%
Total Long-Term Assets $3.700M $3.741M $3.828M
YoY Change -2.6% -2.61% -1.32%
TOTAL ASSETS
Total Short-Term Assets $19.40M $20.59M $24.90M
Total Long-Term Assets $3.700M $3.741M $3.828M
Total Assets $23.10M $24.33M $28.72M
YoY Change -25.61% -26.75% 54.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $200.0K $293.7K $437.5K
YoY Change -61.65% -41.25% -43.94%
Accrued Expenses $400.0K $342.6K $325.4K
YoY Change -13.67% -37.01% -64.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $160.4K
YoY Change -7.54%
Long-Term Debt Due $400.0K $200.0K $300.0K
YoY Change 0.0% 0.0% 0.0%
Total Short-Term Liabilities $1.100M $950.4K $1.782M
YoY Change -38.5% -39.33% -20.77%
LONG-TERM LIABILITIES
Long-Term Debt $1.900M $1.900M $2.000M
YoY Change -5.0% -9.52% -9.09%
Other Long-Term Liabilities $1.200M $1.200M $1.300M
YoY Change -7.69% -7.69% 0.0%
Total Long-Term Liabilities $3.100M $3.100M $3.300M
YoY Change -6.06% -8.82% -5.71%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.100M $950.4K $1.782M
Total Long-Term Liabilities $3.100M $3.100M $3.300M
Total Liabilities $4.200M $4.080M $5.039M
YoY Change -17.77% -17.54% -11.45%
SHAREHOLDERS EQUITY
Retained Earnings -$101.0M -$96.82M
YoY Change 9.93% 12.09%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $18.90M $20.25M $23.69M
YoY Change
Total Liabilities & Shareholders Equity $23.10M $24.30M $28.72M
YoY Change -25.61% -26.83% 54.1%

Cashflow Statement

Concept 2015 Q3 2015 Q2 2014 Q4
OPERATING ACTIVITIES
Net Income -$1.580M -$2.033M -$2.370M
YoY Change -37.62% -21.54% -24.28%
Depreciation, Depletion And Amortization $36.00K $38.00K $70.00K
YoY Change -23.4% -25.49% -12.5%
Cash From Operating Activities -$1.390M -$1.540M -$1.950M
YoY Change -39.3% -27.36% -30.36%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K -$40.00K -$100.0K
YoY Change -50.0% -42.86% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$140.0K $2.340M $1.350M
YoY Change -104.61% -114.2% -68.53%
Cash From Investing Activities -$150.0K $2.310M $1.250M
YoY Change -104.98% -113.97% -70.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -90.00K -110.0K -140.0K
YoY Change -10.0% -100.6% 0.0%
NET CHANGE
Cash From Operating Activities -1.390M -1.540M -1.950M
Cash From Investing Activities -150.0K 2.310M 1.250M
Cash From Financing Activities -90.00K -110.0K -140.0K
Net Change In Cash -1.630M 660.0K -840.0K
YoY Change -362.9% -400.0% -164.62%
FREE CASH FLOW
Cash From Operating Activities -$1.390M -$1.540M -$1.950M
Capital Expenditures -$10.00K -$40.00K -$100.0K
Free Cash Flow -$1.380M -$1.500M -$1.850M
YoY Change -39.21% -26.83% -32.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3569161 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1260150 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
20998789 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
357083 USD
CY2015Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
30990029 shares
CY2015Q2 us-gaap Assets Current
AssetsCurrent
20586054 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
155325 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.21
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30990029 shares
us-gaap Share Based Compensation
ShareBasedCompensation
780983 USD
us-gaap Share Based Compensation
ShareBasedCompensation
729413 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
129794 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
153592 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
48349 USD
us-gaap Recognition Of Deferred Revenue
RecognitionOfDeferredRevenue
47349 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30260 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
18943 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-232018 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-209658 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-143793 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-280565 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-547607 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
127000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
17161 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-363859 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
68584 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3825014 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4961637 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16216718 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
28420458 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
21652610 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
11714964 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2026365 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2103880 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
24895783 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1714286 USD
CY2014Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1482608 USD
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
552408 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
61810 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1724190 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
24517 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101044482 USD
CY2015Q2 us-gaap Licenses Revenue
LicensesRevenue
24174 USD
CY2015Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
293726 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3539911 USD
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
437519 USD
CY2014Q4 us-gaap Liabilities
Liabilities
5038730 USD
CY2015Q2 us-gaap Assets
Assets
24326705 USD
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30990029 shares
CY2014Q4 us-gaap Assets
Assets
28723853 USD
CY2015Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
8096 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30990029 shares
CY2014Q2 us-gaap Cost Of Goods Sold
CostOfGoodsSold
USD
CY2015Q2 us-gaap Liabilities
Liabilities
4080207 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
609417 USD
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2015Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
342561 USD
CY2014Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
325400 USD
CY2015Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
121290980 USD
CY2015Q2 us-gaap Notes Payable Current
NotesPayableCurrent
155628 USD
CY2014Q4 us-gaap Notes Payable Current
NotesPayableCurrent
312934 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
20246498 USD
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4867832 USD
CY2015Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
96698 USD
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
96698 USD
CY2014Q2 us-gaap Licenses Revenue
LicensesRevenue
24174 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
950423 USD
CY2015Q2 us-gaap Short Term Investments
ShortTermInvestments
15562897 USD
CY2015Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1781968 USD
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
30990029 shares
CY2015Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1919420 USD
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2014Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
USD
CY2014Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1998049 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
16421 USD
CY2014Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1674719 USD
CY2015Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1210364 USD
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1258713 USD
CY2014Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
950147 USD
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
2624866 USD
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1994421 USD
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2600692 USD
CY2015Q2 us-gaap Interest Expense
InterestExpense
24195 USD
CY2014Q2 us-gaap Interest Expense
InterestExpense
25768 USD
CY2015Q2 us-gaap Investment Income Net
InvestmentIncomeNet
-14619 USD
us-gaap Licenses Revenue
LicensesRevenue
47349 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3018459 USD
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
2035016 USD
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-2591519 USD
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30990029 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30782937 shares
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
35805 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
51728 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
12103 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
31907 USD
us-gaap Gross Profit
GrossProfit
23702 USD
us-gaap Gross Profit
GrossProfit
19821 USD
us-gaap Licenses Revenue
LicensesRevenue
48349 USD
CY2014Q2 us-gaap Investment Income Net
InvestmentIncomeNet
34941 USD
CY2015Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-38814 USD
CY2014Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
9173 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-2033235 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2002445 USD
us-gaap Operating Expenses
OperatingExpenses
4278609 USD
us-gaap Operating Expenses
OperatingExpenses
5571606 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-4206558 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5504436 USD
us-gaap Interest Expense
InterestExpense
49259 USD
us-gaap Interest Expense
InterestExpense
62558 USD
us-gaap Investment Income Net
InvestmentIncomeNet
36209 USD
us-gaap Investment Income Net
InvestmentIncomeNet
27826 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13050 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-34732 USD
us-gaap Net Income Loss
NetIncomeLoss
-4219608 USD
us-gaap Net Income Loss
NetIncomeLoss
-5539168 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26236252 shares
CY2015Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
24000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1600 USD
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6200000 shares
CY2014Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5300000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5300000 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2200 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
47022 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
113304 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5388870 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16820998 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
235935 USD
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
245933 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-235935 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19876719 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1327921 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1905916 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5658683 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3752767 USD
us-gaap Interest Paid
InterestPaid
49740 USD
us-gaap Interest Paid
InterestPaid
52928 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
4647 USD
us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20122652 USD
CY2015Q2 us-gaap Investments And Cash
InvestmentsAndCash
20431000 USD
CY2015Q2 appy Working Capital
WorkingCapital
19636000 USD
CY2015Q2 appy Percentage Of Investment Portfolio Cash And Cash Equivalent
PercentageOfInvestmentPortfolioCashAndCashEquivalent
0.20 pure
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
12000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6200000 shares
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5391044 USD
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5391044 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3364679 USD
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3287164 USD
CY2014Q4 us-gaap Goodwill
Goodwill
387239 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
5000 USD
CY2015Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
USD
CY2014Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
160375 USD
CY2015Q2 us-gaap Notes Payable
NotesPayable
2075048 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
82000 USD
CY2014Q4 us-gaap Notes Payable
NotesPayable
2310983 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
16000 USD
CY2015Q2 us-gaap Depreciation
Depreciation
38000 USD
us-gaap Depreciation
Depreciation
78000 USD
CY2014Q2 us-gaap Depreciation
Depreciation
51000 USD
us-gaap Depreciation
Depreciation
103000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
559922 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
507644 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1327047 USD
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1336951 USD
CY2015Q2 us-gaap Goodwill
Goodwill
387239 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
97000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
97000 USD
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
97000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
97000 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
97000 USD
CY2015Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
5000 USD
CY2014Q2 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
USD
CY2015Q2 us-gaap Secured Debt
SecuredDebt
2075048 USD
CY2014Q4 us-gaap Secured Debt
SecuredDebt
2150608 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
1268000 USD
CY2014Q2 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
1543000 USD
CY2014Q2 appy Placement Fee Percentage
PlacementFeePercentage
0.065 pure
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
1161570 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.36
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1580000 USD
CY2014Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39079 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
14000 USD
CY2014Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
8335000 shares
CY2014Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
2.40
CY2014Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
20000000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
77000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
159000 USD
CY2015Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
166000 USD
CY2015Q2 appy Long Term Debt Maturities Repayments Of Principal After Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearSix
238000 USD
CY2015Q2 appy Long Term Debt Maturities Repayments Of Principal In Year Six
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearSix
85000 USD
CY2014Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.09
CY2014Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
82000 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
1912205 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
3673126 shares
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
347581 USD
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
326392 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
780983 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
729413 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0 shares
appy Prior Written Notice Period For Termination Of License Agreement By Licensee
PriorWrittenNoticePeriodForTerminationOfLicenseAgreementByLicensee
P180D
CY2015Q2 appy License Agreement Maximum Milestone Payments
LicenseAgreementMaximumMilestonePayments
1100000 USD
CY2015Q2 appy Additional Milestone Maximum Payments
AdditionalMilestoneMaximumPayments
2000000 USD
CY2015Q2 us-gaap Other Commitment Due In Next Twelve Months
OtherCommitmentDueInNextTwelveMonths
20000 USD
CY2015Q2 appy License And Milestone Payments Revenue
LicenseAndMilestonePaymentsRevenue
1920000 USD
CY2015Q2 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
363700 USD
CY2015Q2 appy Deferred Revenue Gross
DeferredRevenueGross
1556300 USD
CY2015Q2 appy Deferred Revenue Accumulated Recognition
DeferredRevenueAccumulatedRecognition
249238 USD
CY2015Q2 us-gaap Deferred Revenue
DeferredRevenue
1307062 USD
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P197M
CY2015Q2 us-gaap Contractual Obligation
ContractualObligation
10000 USD
CY2014Q4 us-gaap Contractual Obligation
ContractualObligation
10000 USD
dei Entity Registrant Name
EntityRegistrantName
Venaxis, Inc.
dei Entity Central Index Key
EntityCentralIndexKey
0001167419
dei Document Period End Date
DocumentPeriodEndDate
2015-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2

Files In Submission

Name View Source Status
0001079973-15-000532-index-headers.html Edgar Link pending
0001079973-15-000532-index.html Edgar Link pending
0001079973-15-000532.txt Edgar Link pending
0001079973-15-000532-xbrl.zip Edgar Link pending
appy-20150630.xml Edgar Link completed
appy-20150630.xsd Edgar Link pending
appy-20150630_cal.xml Edgar Link unprocessable
appy-20150630_def.xml Edgar Link unprocessable
appy-20150630_lab.xml Edgar Link unprocessable
appy-20150630_pre.xml Edgar Link unprocessable
appy_10q-063015.htm Edgar Link pending
ex31x1.htm Edgar Link pending
ex31x2.htm Edgar Link pending
ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending